{
  "meta": {
    "title": "25_Hypertensive_Disorders_In_Pregnancy",
    "url": "https://brainandscalpel.vercel.app/25-hypertensive-disorders-in-pregnancy-b7355632.html",
    "scrapedAt": "2025-11-30T12:29:55.529Z"
  },
  "questions": [
    {
      "text": "Gestational hypertension is defined as:",
      "choices": [
        {
          "id": 1,
          "text": "BP>130/80 after 22 weeks of gestation"
        },
        {
          "id": 2,
          "text": "BP > 130/80 after 20 weeks of gestation"
        },
        {
          "id": 3,
          "text": "BP >  140/90 after 22 weeks of gestation"
        },
        {
          "id": 4,
          "text": "BP >  140/90 after 20 weeks of gestation"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Gestational hypertension</strong> is defined as&nbsp;<strong>BP &gt;140/90 </strong>after<strong> 20 weeks</strong> of gestation.</p>\n<p>Hypertension in pregnancy is defined as BP of &gt;140/90 mmHg measured 2 times with at least a 4-hour interval.</p>\n<table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><strong>Gestational hypertension</strong></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><strong>Pre-eclampsia</strong></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><strong>Chronic hypertension in pregnancy</strong></p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><strong>Rise in BP</strong></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">After 20 weeks of pregnancy</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">After 20 weeks of pregnancy</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Before 20 weeks of gestation</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><strong>Proteinuria</strong></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Absent</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">May be present:</p>\n<ul>\n<li class=\"p1\">&gt;300 mg in 24 hrs urine&nbsp;</li>\n<li class=\"p1\">&gt;30 mg/dl in a random urine sample</li>\n<li class=\"p1\">Urine dipstick 2+</li>\n</ul>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Absent</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><strong>Fall in BP to normal levels</strong></td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Within 12 weeks of delivery</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Within 12 weeks of delivery</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Does not return to normal&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Proteinuria is not an essential criterion to define pre-eclampsia.</p>\n<p><strong>Pre-eclampsia</strong> is <strong>hypertension</strong> with <strong>any</strong> of the following features:</p>\n<ul>\n<li>Proteinuria</li>\n<li>Thrombocytopenia</li>\n<li>Renal insufficiency</li>\n<li>Liver involvement</li>\n<li>Cerebral symptoms</li>\n<li>Pulmonary edema.</li>\n</ul>\n<p>Note:&nbsp;A normotensive pregnant woman may have an acute increase in BP from baseline levels and develop eclamptic seizures/HELLP syndrome, despite being normotensive. This condition is known as&nbsp;<strong>delta hypertension.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2035",
      "difficulty": "easy"
    },
    {
      "text": "What is the minimum cut-off for defining proteinuria in a random urine sample?",
      "choices": [
        {
          "id": 1,
          "text": "0.3 g/L"
        },
        {
          "id": 2,
          "text": "0.2 g/L"
        },
        {
          "id": 3,
          "text": "0.1 g/L"
        },
        {
          "id": 4,
          "text": "0.4 g/L"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The cut-off for defining proteinuria is<strong> ≥30 mg/dl </strong>(0.3 g/L)<strong> </strong>in a random urine sample.</p>\n<p>Proteinuria in preeclampsia is also defined by:</p>\n<ul>\n<li class=\"bulletIndent2\">≥0.3 g protein in a 24-hour urine specimen.  </li>\n<li class=\"bulletIndent2\">Random urine protein: creatinine ratio (PCR) ≥0.3 mg protein/mg creatinine </li>\n<li>Protein ≥1+ on urine dipstick</li>\n</ul>\n<p>A urine dipstick is used only if the above quantitative methods are not available.</p>\n<p>Note: Proteinuria is not an essential criterion to define pre-eclampsia.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2037",
      "difficulty": "easy"
    },
    {
      "text": "In a normal pregnancy, when does the remodeling of spiral arteries begin?",
      "choices": [
        {
          "id": 1,
          "text": "6 weeks"
        },
        {
          "id": 2,
          "text": "16 weeks"
        },
        {
          "id": 3,
          "text": "14 weeks"
        },
        {
          "id": 4,
          "text": "12 weeks"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>In a normal pregnancy, the<strong> remodeling</strong> of <strong>spiral arteries</strong> begins at <strong>12 weeks</strong>.</p>\n<p>Remodeling of arteries includes invasion of arteries by trophoblasts that convert them from low-flow,<strong> high-resistance</strong> <strong>to</strong> high-flow,<strong> low-resistance</strong> vessels. These modified vessels are more capable of meeting the demands of the developing fetus.</p>\n<p><strong>Uteroplacental vessel development</strong> takes place in two stages:</p>\n<p>The<strong> first stage</strong> occurs <strong>before 12 weeks</strong> post-fertilization. During this stage, <strong>invasion</strong> of<strong> spiral arteries</strong> up to <strong>myometrium </strong>occurs.</p>\n<p>The <strong>second stage</strong> occurs between<strong> 12-16 weeks. </strong>It involves <strong>invasion</strong> of the <strong>endovascular trophoblasts</strong> into the<strong> </strong>intra-myometrial segments of <strong>spiral arteries</strong>.<strong> </strong>Interstitial trophoblasts surround the arteries.</p>\n<p><strong>Incomplete</strong> <strong>trophoblastic invasion</strong> leads to pregnancy-induced hypertension (<strong>PIH</strong>) where the vessels remain in a state of <strong>high resistance</strong> leading to <strong>placental ischemia</strong> and release of inflammatory mediators and vasoactive substances leading to<strong> endothelial injury.</strong> </p>\n<p>As the second stage of invasion occurs by 18 weeks, PIH develops after 20 weeks of pregnancy.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9708",
      "difficulty": "medium"
    },
    {
      "text": "A 28-year-old G2P1 patient at 17 weeks of gestation comes for a routine antenatal visit. Her blood pressure is 142/94 mm of Hg. A repeat blood pressure after 4 hours is measured to be 148/92 mm Hg. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Preeclampsia"
        },
        {
          "id": 2,
          "text": "Preeclampsia superimposed on chronic hypertension"
        },
        {
          "id": 3,
          "text": "Chronic hypertension"
        },
        {
          "id": 4,
          "text": "Gestational hypertension"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In the above scenario of hypertension in a patient with gestational age &lt;20 weeks, the diagnosis is <strong>chronic hypertension.&nbsp;</strong></p>\n<p>Chronic hypertension is diagnosed when the&nbsp;patient is a<strong>&nbsp;known </strong><strong>hypertensive&nbsp;</strong>(or)&nbsp;<strong>BP &gt; 140/90</strong> mmHg <strong>before&nbsp;20 weeks </strong>of gestation.</p>\n<p>Gestational hypertension and preeclampsia are only diagnosed&nbsp;after 20 weeks of gestation.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2039",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following does not put a patient at an increased risk for preeclampsia?",
      "choices": [
        {
          "id": 1,
          "text": "Twin pregnancy"
        },
        {
          "id": 2,
          "text": "Family history of hypertension"
        },
        {
          "id": 3,
          "text": "New paternity"
        },
        {
          "id": 4,
          "text": "Smoking"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Smoking</strong> is not a risk factor for pre-eclampsia rather it is <strong>protective</strong>.</p>\n<p>Although <strong>smoking</strong> during pregnancy causes various adverse pregnancy outcomes, it is associated with a <strong>reduced risk </strong>for<strong> hypertension in pregnancy.</strong></p>\n<p>Risk factors for pre-eclampsia are:</p>\n<ul>\n<li>Previous history of pre-eclampsia</li>\n<li>Primigravida: young or elderly</li>\n<li><strong>Family history</strong>: <strong>Hypertension</strong>, pre-eclampsia.</li>\n<li>Placental abnormalities:\n<ul>\n<li>Hyperplacentosis: excessive exposure to chorionic villi (molar pregnancy, twins, diabetes)</li>\n<li>Placental ischemia</li>\n</ul>\n</li>\n<li>Thrombophilias: <strong>APLA</strong>, Protein C, Protein S deficiency, Factor V laden mutation, homocysteinemia</li>\n<li><strong>Twin pregnancy</strong></li>\n<li>Molar pregnancy</li>\n<li>Rh-negative pregnancy</li>\n<li><strong>New paternity</strong> - A new partner for subsequent pregnancies</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2041",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following does not occur in patients developing pre-eclampsia?",
      "choices": [
        {
          "id": 1,
          "text": "Abnormal trophoblastic invasion of uterine vessels"
        },
        {
          "id": 2,
          "text": "Maladaptive immunological tolerance to fetal antigens"
        },
        {
          "id": 3,
          "text": "Maladaptation to cardiovascular changes of normal pregnancy"
        },
        {
          "id": 4,
          "text": "Increased placental perfusion due to inflammation"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Placental perfusion</strong> is <strong>reduced</strong> in patients developing <strong>pre-eclampsia.</strong></p>\n<p>The development of pre-eclampsia may be explained by:</p>\n<ul>\n<li><strong>Abnormal trophoblastic invasion</strong> of uterine vessels, leading to decreased placental perfusion.</li>\n<li>Maternal inflammatory response directed against foreign fetal antigens leading to <strong>immunological maladaptation</strong>.</li>\n<li>Maternal <strong>maladaptation</strong> to <strong>cardiovascular</strong> and inflammatory <strong>changes</strong> of normal pregnancy.</li>\n<li>Genetic factors and&nbsp;epigenetic influences.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2042",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is false regarding the management of patients with an increased risk of pre-eclampsia?",
      "choices": [
        {
          "id": 1,
          "text": "Low dose aspirin may reduce severity of disease"
        },
        {
          "id": 2,
          "text": "Calcium supplementation above RDA reduces the incidence"
        },
        {
          "id": 3,
          "text": "Treatment with magnesium lowers endothelin-1 concentrates"
        },
        {
          "id": 4,
          "text": "Megadoses of vitamin C has no proven benefit"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Calcium supplementation above the RDA does not reduce&nbsp;the&nbsp;incidence of pre-eclampsia.&nbsp;</p>\n<p>However, women who have a <strong>calcium-deficient state</strong> <strong>may benefit</strong> from calcium supplementation to reduce their risk of preeclampsia.&nbsp;</p>\n<p>Prophylactic measures for the prevention of pre-eclampsia include <strong>low-dose&nbsp;aspirin </strong>administration&nbsp;(50&ndash;150 mg/day). It is started after the 1st trimester, continued throughout pregnancy, and is to be stopped 7 days before labor.</p>\n<p><strong>Magnesium</strong> administration may be beneficial as it lowers endothelin-1 concentrates.</p>\n<p>There is no role of a low salt diet, anti-oxidants, or vitamin C.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2044",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is false regarding the pathogenesis of pre-eclampsia?",
      "choices": [
        {
          "id": 1,
          "text": "Vascular sensitivity to angiotensin 2 is increased"
        },
        {
          "id": 2,
          "text": "Angiotensinase activity is depressed"
        },
        {
          "id": 3,
          "text": "There is an increase in sFlt -1 levels"
        },
        {
          "id": 4,
          "text": "A decrease in the level of soluble endoglin is seen"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>In pre-eclampsia, there is an&nbsp;<strong>increase </strong>in the level of<strong> soluble endoglin</strong>.</p>\n<p>Excessive amounts of antiangiogenic factors,&nbsp;increased sensitivity to angiotensin, and lowered angiotensinase levels <strong>worsen hypoxia</strong> at the uteroplacental interface.</p>\n<div class=\"page\" title=\"Page 754\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 754\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Trophoblast of women who develop preeclampsia overproduces at least two<strong> antiangiogenic peptides</strong> that enter the maternal circulation. They&nbsp;<strong>increase</strong> months before clinical preeclampsia develops.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<ul>\n<li>Soluble <strong>endoglin </strong>(sEng)&nbsp;is derived from the placenta and <strong>blocks</strong> endothelial nitric oxide-dependent <strong>vasodilatation.</strong> It also inhibits various TGF&beta; isoforms from binding to endothelial receptors.</li>\n</ul>\n<div class=\"page\" title=\"Page 754\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Soluble <strong>Fms-like tyrosine kinase 1</strong> (sFlt-1)&nbsp;is a variant of the Flt-1 receptor for placental growth factor (PlGF) and for VEGF.&nbsp;Increased maternal sFlt-1 levels inactivate and decrease circulating free PlGF and VEGF concentrations, leading to <strong>endothelial dysfunction.</strong></li>\n</ul>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2045",
      "difficulty": "medium"
    },
    {
      "text": "A 24-year-old primigravida at 22 weeks of gestation came for a regular antenatal checkup. Her BP is 152/96mmHg. Urine analysis shows proteinuria of 3+. All of the following would be consistent with her probable diagnosis, except:",
      "choices": [
        {
          "id": 1,
          "text": "Thrombocytopenia"
        },
        {
          "id": 2,
          "text": "Hemolysis"
        },
        {
          "id": 3,
          "text": "Increased Hemoglobin"
        },
        {
          "id": 4,
          "text": "Low fibronectin"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical picture is suggestive of <strong>pre-eclampsia</strong> and low&nbsp;fibronectin is not a feature of pre-eclampsia.</p>\n<p>Features associated with pre-eclampsia:</p>\n<ul>\n<li><strong>Fibronectin</strong> is&nbsp;a glycoprotein associated with vascular endothelial cell basement membrane and is <strong>elevated</strong> in women with preeclampsia.</li>\n<li><strong>Thrombocytopenia</strong> (HELLP syndrome)</li>\n<li><strong>Hemolysis</strong> (HELLP syndrome)</li>\n<li><strong>Increased hemoglobin</strong>,&nbsp;caused by a decrease in plasma volume.</li>\n</ul>\n<p>Hemoconcentration is a hallmark of eclampsia. In&nbsp;preeclampsia,&nbsp;hemoconcentration is present but usually not marked.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2046",
      "difficulty": "hard"
    },
    {
      "text": "Which finding is most likely to be seen in a patient with pre-eclampsia?",
      "choices": [
        {
          "id": 1,
          "text": "Low uric acid level"
        },
        {
          "id": 2,
          "text": "Decreased GFR"
        },
        {
          "id": 3,
          "text": "Low serum creatinine level"
        },
        {
          "id": 4,
          "text": "High urinary calcium"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Decreased GFR</strong> is seen in pre-eclampsia.</p>\n<p>During normal pregnancy, renal blood flow and GFR are increased. However, in pre-eclampsia, <strong>renal blood flow</strong> and <strong>GFR decrease</strong>&nbsp;due to <strong>increased</strong> renal <strong>afferent arteriolar</strong> <strong>resistance</strong>.&nbsp;The hallmark renal lesion is <strong>glomerular endotheliosis</strong>.&nbsp;Diminished filtration causes serum <strong>creatinine levels</strong> and plasma <strong>uric acid</strong> concentration levels to <strong>rise</strong>. The elevation is also due to enhanced tubular reabsorption.</p>\n<p>The most common system involved in pre-eclampsia is the renal system.</p>\n<p>Several studies have demonstrated that pre-eclampsia is associated with <strong>low urinary calcium</strong>. This is often used as a predictive test.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2048",
      "difficulty": "easy"
    },
    {
      "text": "Ophthalmic manifestations in patients with  preeclampsia syndrome include all, except:",
      "choices": [
        {
          "id": 1,
          "text": "Purtscher’s retinopathy causing reversible blindness"
        },
        {
          "id": 2,
          "text": "Central vision loss due to temporary scotoma"
        },
        {
          "id": 3,
          "text": "Permanent visual loss due to retinal artery occlusion"
        },
        {
          "id": 4,
          "text": "Permanent blindness due to serous retinal detachment"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p class=\"p1\">Serous retinal detachment does not cause permanent visual loss. </p>\n<p>The<strong> most common</strong> visual symptom of preeclampsia is <strong>scotoma.</strong> </p>\n<p>Blindness can be due to <strong>occipital cortex edema</strong>, <strong>Purtscher’s retinopathy </strong>(retinal ischemia), or <strong>retinal detachment</strong>. The blindness is mostly reversible and corrects automatically after delivery. </p>\n<p><strong>Retinal artery occlusion</strong> sometimes causes permanent vision loss.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2049",
      "difficulty": "medium"
    },
    {
      "text": "A patient, diagnosed with preeclampsia was brought to the emergency room with three episodes of generalized tonic-clonic seizures, urinary incontinence, and altered sensorium for 3 hours. After stabilization, an MRI revealed the following findings. Which of the following is true regarding this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Anterior circulation is most commonly involved"
        },
        {
          "id": 2,
          "text": "This lesions may be seen in most pre-eclampsia patients"
        },
        {
          "id": 3,
          "text": "The condition is reversible"
        },
        {
          "id": 4,
          "text": "Basal ganglia are always spared"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The above clinical scenario and radiological image are suggestive of posterior reversible leukoencephalopathy syndrome (<strong>PRES</strong>). This condition is usually <strong>reversible.</strong></p>\n<p><strong>Endothelial dysfunction</strong> and <strong>cerebral autoregulation failure</strong> are implicated as etiologies of PRES.&nbsp;PRES lesions are almost universal in women with <strong>eclampsia</strong> but less frequent in pre-eclampsia.</p>\n<p>PRES&nbsp;is characterized by the following:</p>\n<ul>\n<li>Severe headaches</li>\n<li>Altered sensorium</li>\n<li>Seizures</li>\n<li>Visual disturbances.&nbsp;</li>\n</ul>\n<p>Radiological findings in PRES:</p>\n<ul>\n<li>Hyperintense T2 lesions in the subcortical and cortical regions of the <strong>parietal </strong>and<strong> occipital lobes</strong>.</li>\n<li>The <strong>basal ganglia</strong>, brainstem,&nbsp;and cerebellum are commonly <strong>involved</strong>.</li>\n<li><strong>Posterior circulation </strong>is commonly<strong> involved,</strong> and anterior circulation involvement is seen in severe cases.</li>\n</ul><p>Neurological manifestations of preeclampsia include:</p>\n<ul>\n<li>Headaches&nbsp;</li>\n<li>Convulsions</li>\n<li>Cerebral edema</li>\n<li>Blindness&nbsp;</li>\n<li>Cerebral hemorrhage.</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/d254b47cff98469099683e58007a5e84.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2050",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following are indicators of severe disease in a patient with preeclampsia?<div class='question-desc-html'><ol>\n<li>Pulmonary edema</li>\n<li>Systolic BP &gt;130 mmHg</li>\n<li>Mild headache</li>\n<li>Scotoma</li>\n<li>Epigastric pain</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 3, 2, 5"
        },
        {
          "id": 2,
          "text": "1, 4, 5"
        },
        {
          "id": 3,
          "text": "2, 3, 4, 5"
        },
        {
          "id": 4,
          "text": "1, 3, 4"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Among the given statements, the presence of <strong>pulmonary edema, scotoma,</strong> or<strong> epigastric pain</strong> is indicative of <strong>severe pre-eclampsia</strong>.&nbsp;</p>\n<p>Criteria for diagnosing severe preeclampsia include:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Systolic BP</strong></td>\n<td><strong>Diastolic BP</strong></td>\n<td><strong>Proteinuria</strong></td>\n<td><strong>Signs of end-organ damage</strong></td>\n</tr>\n<tr>\n<td>&ge;160 mmHg</td>\n<td>&ge;110 mmHg</td>\n<td>+</td>\n<td>+/-</td>\n</tr>\n<tr>\n<td>&ge;140 mmHg</td>\n<td>&ge;90 mmHg</td>\n<td>+/-</td>\n<td>+</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Signs and symptoms of significant <strong>end-organ dysfunction</strong> are:</p>\n<ul>\n<li><strong>New-onset</strong> cerebral or visual disturbance i.e., photopsia, <strong>scotoma</strong>, altered mental status, and&nbsp;<strong>severe headache</strong></li>\n<li>Severe, persistent <strong>right upper quadrant</strong> or <strong>epigastric pain</strong>, unresponsive to medication and not accounted for by an alternative diagnosis&nbsp;(OR)&nbsp;Serum transaminase concentration &ge;2 times upper limit of normal.</li>\n<li><strong>Thrombocytopenia</strong> with platelets &lt;100,000<span class=\"nowrap\">/microL</span>.</li>\n<li>Progressive <strong>renal insufficiency</strong> (serum creatinine &gt;1.1&nbsp;<span class=\"nowrap\">mg/dL)</span></li>\n<li>Pulmonary edema.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2052",
      "difficulty": "easy"
    },
    {
      "text": "A patient at 32 weeks of gestation with pre-eclampsia is admitted to your ward. All of the following symptoms would warn you of impending eclampsia, except:",
      "choices": [
        {
          "id": 1,
          "text": "Ankle clonus"
        },
        {
          "id": 2,
          "text": "Oliguria"
        },
        {
          "id": 3,
          "text": "Scotoma"
        },
        {
          "id": 4,
          "text": "Decreased deep tendon reflex"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p class=\"p1\">Decreased deep tendon reflex is not a symptom of impending&nbsp;eclampsia. There will be <strong>increased deep tendon reflex</strong> i.e.,<strong>&nbsp;</strong>hyperreflexia.</p>\n<p>Symptoms and signs of <strong>impending eclampsia</strong> include:</p>\n<ul>\n<li>Severe occipital or frontal headache</li>\n<li><strong>Oliguria - </strong>diminished urine output &lt;400 ml/day</li>\n<li>Epigastric pain</li>\n<li>Visual symptoms - blurring, <strong>scotomas</strong>, blindness</li>\n<li>Disturbed sleep</li>\n<li><strong>Ankle clonus</strong></li>\n<li>Severe elevation in blood pressure</li>\n<li>Pulmonary edema.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2053",
      "difficulty": "easy"
    },
    {
      "text": "A G2P1 woman with a history of pre-eclampsia presents at 24 weeks of gestation for an antenatal check-up. You decide to evaluate her risk of developing pre-eclampsia in the present pregnancy. Which of the following results is not an indicator?",
      "choices": [
        {
          "id": 1,
          "text": "Absence of diastolic notch on Doppler"
        },
        {
          "id": 2,
          "text": "High resistance index in uterine artery Doppler in the second trimester"
        },
        {
          "id": 3,
          "text": "Average MAP > 90 mmHg"
        },
        {
          "id": 4,
          "text": "Presence of free fetal DNA in maternal serum"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In this above scenario, the<strong> </strong>absence of a diastolic notch at 24 weeks on Doppler is not a predictor of pre-eclampsia.</p>\n<p>In <strong>normal</strong> pregnant women, a <strong>diastolic notch</strong> in the uterine artery <strong>disappears</strong> <strong>by 24 weeks</strong>. Thus, a <strong>persistent</strong> diastolic notch present in uterine artery flow between <strong>22-24 weeks</strong> is predictive of <strong>preeclampsia.</strong></p>\n<p> Predictors of preeclampsia:</p>\n<ul>\n<li>Free fetal DNA in maternal plasma</li>\n<li>Diastolic notch present in uterine artery flow between 22-24 weeks (high resistance index in the second trimester)</li>\n<li>Average MAP &gt;90 mmHg</li>\n</ul>\n<p>Predictors no longer used include:</p>\n<ul>\n<li>Hemoconcentration</li>\n<li>Elevated fibronectin</li>\n<li>Increase in uric acid levels</li>\n<li>Hypocalciuria - calcium in urine &lt;12mg/dl in 24 h</li>\n<li>Increased homocysteine levels</li>\n<li>Roll-over test - screening test is done between 28-32 weeks.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2054",
      "difficulty": "hard"
    },
    {
      "text": "A 30-year-old G3P2 at 34 weeks of gestation was admitted as her BP was 150/90mmHg and urine dipstick was 2+ on antenatal checkup. Which of the following drugs is not suitable to control BP in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Methyl dopa"
        },
        {
          "id": 2,
          "text": "Labetalol"
        },
        {
          "id": 3,
          "text": "Hydralazine"
        },
        {
          "id": 4,
          "text": "Captopril"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Captopril</strong> is an <strong>ACE inhibitor</strong> and it is <strong>contraindicated</strong> in pregnancy.</p>\n<p>High BP and proteinuria are diagnostic of <strong>preeclampsia</strong>. The following drugs are used for the management of pre-eclampsia.</p>\n<table>\n<tbody>\n<tr>\n<td>Drug</td>\n<td>Dose</td>\n</tr>\n<tr>\n<td><strong>Labetalol</strong></td>\n<td>\n<div>\n<div>\n<div>\n<div>\n<p>100 mg TID or QID</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>\n<div>\n<div>\n<div>\n<p><strong>Methyl-dopa</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div>\n<div>\n<div>\n<div>\n<p>250&ndash;500 mg TID or QID</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>\n<div>\n<div>\n<div>\n<p><strong>Nifedipine</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div>\n<div>\n<div>\n<div>\n<p>10&ndash;20 mg BD</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>\n<div>\n<div>\n<div>\n<p><strong>Hydralazine</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div>\n<div>\n<div>\n<div>\n<p>10&ndash;25 mg BD</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>ACE inhibitors</strong>&nbsp;inhibit the <strong>conversion</strong> of <strong>angiotensin I</strong> to the potent vasoconstrictor<strong> angiotensin-II.</strong> When given in the second and third trimesters, they can cause severe <strong>fetal malformations </strong>such as:</p>\n<ul>\n<li>Bony malformations</li>\n<li>Persistent PDA</li>\n<li>Respiratory distress syndrome</li>\n<li>Limb contracture</li>\n<li>Pulmonary hypoplasia.</li>\n</ul>\n<p>Anti-hypertensives to be avoided in pregnancy include:</p>\n<ul>\n<li><strong>ACE inhibitors</strong></li>\n<li>Angiotensin receptor blockers&nbsp;</li>\n<li>Diuretics (contraindicated as anti-hypertensive but can be given in CCF)</li>\n<li>Reserpine</li>\n<li>Sodium nitroprusside (used only as a drug of last resort in refractory severe hypertension)</li>\n<li>Diazoxide.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2056",
      "difficulty": "easy"
    },
    {
      "text": "Which is the drug of choice for controlling BP in a patient with severe pre-eclampsia?",
      "choices": [
        {
          "id": 1,
          "text": "Labetalol"
        },
        {
          "id": 2,
          "text": "Hydralazine"
        },
        {
          "id": 3,
          "text": "Nifedipine"
        },
        {
          "id": 4,
          "text": "Methyldopa"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Intravenous<strong> labetalol</strong>&nbsp;is the drug of choice for controlling BP in severe pre-eclampsia.</p>\n<p class=\"p1\">It is the first-line agent for urgent control of BP in pregnancy. It is effective, has a rapid onset of action, and has a good safety profile.</p>\n<p class=\"p1\">Labetalol is a <strong>nonselective&nbsp;&beta; blocker</strong> and <strong>vascular&nbsp;&alpha; blocker.</strong> It should be <strong>avoided</strong> in patients with<strong> asthma</strong> and <strong>congestive heart failure</strong> due to bronchoconstriction.</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Choice of anti-hypertensives in pregnancy</strong></td>\n</tr>\n<tr>\n<td>PIH /pre-eclampsia / severe pre-eclampsia</td>\n<td>Labetalol</td>\n</tr>\n<tr>\n<td>Acute hypertension/ Hypertensive crisis</td>\n<td>IV labetalol, nifedipine, hydralazine</td>\n</tr>\n<tr>\n<td>Chronic hypertension in pregnancy</td>\n<td>Labetalol &gt; methyl dopa.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Option B: <strong>Hydralazine</strong> causes <strong>maternal hypotension</strong> and <strong>fetal distress</strong>.</p>\n<p>Option C: <strong>Nifedipine</strong> causes reflex<strong> tachycardia</strong> and <strong>headache</strong> in the <strong>mother</strong>.</p>\n<p>Option D: In <strong>methyldopa</strong>, a change in BP is an indirect action. So it is <strong>less effective</strong> in controlling BP.</p>\n<p>Note:&nbsp;Experimental antihypertensive drugs for pre-eclampsia treatment are&nbsp;calcitonin gene-related peptide (<strong>CGRP</strong>) and&nbsp;anti-digoxin antibody Fab (<strong>DIF</strong>). DIF is directed against endogenous digitalis-like factors, also called <strong>cardiotonic steroids.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2057",
      "difficulty": "easy"
    },
    {
      "text": "A G3P1A1, preeclamptic patient at 33 weeks of gestation came for a regular antenatal check-up.  At present, her BP is 130/90 and an NST is reactive. What is the plan of management for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Wait till 37 weeks for delivery"
        },
        {
          "id": 2,
          "text": "Deliver at term"
        },
        {
          "id": 3,
          "text": "Induce at 34 weeks"
        },
        {
          "id": 4,
          "text": "Perform LSCS at 34 weeks"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The scenario is suggestive of <strong>mild pre-eclampsia</strong> as the patient has&nbsp;a BP of 130/90 mmHg and no fetal compromise. Hence, the plan of management would be to wait till <strong>37 weeks</strong> for termination.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Hypertensive condition</strong></p>\n</td>\n<td>\n<p><strong>Time of delivery</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gestational hypertension</p>\n</td>\n<td>\n<p>38&ndash;39 weeks</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mild pre-eclampsia</p>\n</td>\n<td>\n<p>&ge;37 weeks</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Severe pre-eclampsia</p>\n</td>\n<td>\n<p>&ge;34 weeks</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Eclampsia, HELLP syndrome</p>\n</td>\n<td>\n<p>Immediate termination irrespective of gestational age</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>In all cases of hypertension during pregnancy, the preferred mode of delivery is <strong>vaginal</strong>. Cesarean is indicated only for any co-existing obstetrical reasons.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2073",
      "difficulty": "easy"
    },
    {
      "text": "A 33-week-pregnant lady with pre-eclampsia presents with features suggestive of HELLP syndrome. Which of the following is false about her condition?",
      "choices": [
        {
          "id": 1,
          "text": "Corticosteroids aid in increasing platelet count"
        },
        {
          "id": 2,
          "text": "It is characterised by microangiopathic hemolysis"
        },
        {
          "id": 3,
          "text": "MgSO4 can be used in the management of HELLP syndrome"
        },
        {
          "id": 4,
          "text": "Termination of pregnancy is the definitive management"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Corticosteroid treatment for thrombocytopenia is not recommended in patients with <strong>HELLP</strong> syndrome.</p>\n<p>HELLP syndrome is a serious complication in pregnancy characterized by <strong>HE</strong>molysis<strong>,</strong> <strong>EL</strong>evated liver enzymes, and <strong>L</strong>ow<strong> P</strong>latelet count. It occurs in 0.5-0.9% of all pregnancies and in 10–20% of patients with severe preeclampsia.  </p>\n<p><strong>Management</strong> of HELLP syndrome is supportive, including: <br />- Antiseizure prophylaxis with <strong>MgSO<sub>4</sub></strong> <br />- Platelet tansfusion if platelet count &lt;50,000/mm3 , FFP transfusion <br />- Plasmapheresis <br />- <strong>Immediate termination </strong>of pregnancy in the interest of the mother.<br /><br /> The most common cause of maternal death in HELLP syndrome is <strong>abruptio placenta</strong> and<strong> DIC</strong>. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2061",
      "difficulty": "medium"
    },
    {
      "text": "Which among the following is false regarding HELLP syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "PT,  PTT,  fibrinogen levels are normal"
        },
        {
          "id": 2,
          "text": "All patients with HELLP syndrome have abnormal BP"
        },
        {
          "id": 3,
          "text": "Tennessee criteria is used for diagnosis"
        },
        {
          "id": 4,
          "text": "It usually manifests at 27-37 weeks"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>15%</strong> of pregnant women with HELLP syndrome have <strong>normal blood pressure.</strong></p>\n<p>HELLP syndrome&nbsp;occurs at&nbsp;27-37 weeks.&nbsp;PT, PTT, and fibrinogen levels&nbsp;are normal. This differs from DIC where PT and PTT are elevated while the plasma fibrinogen level is decreased.</p>\n<p><strong>Tennessee criteria</strong> is used for <strong>diagnosis</strong> and <strong>Mississippi classification</strong> is used to <strong>grade</strong> HELLP syndrome.</p>\n<ul>\n<li>Tennessee criteria for diagnosis of true/complete HELLP\n<ul>\n<li>Platelet count &lt;1 lakh/cu mm</li>\n<li>AST &gt;70 IU/L,&nbsp;</li>\n<li>LDH &gt;600 IU/L</li>\n</ul>\n</li>\n<li>Mississippi classification divides HELLP into 3 grades based on the platelet count.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9713",
      "difficulty": "medium"
    },
    {
      "text": "A G2P1 patient at 25 weeks of gestation is brought to the emergency with right upper quadrant pain and one episode of seizure. CBC reveals a Hb of 7.6gm/dl and a platelet count of 70,000/microL. What is the definitive management?",
      "choices": [
        {
          "id": 1,
          "text": "Termination of  pregnancy"
        },
        {
          "id": 2,
          "text": "Administration of steroids"
        },
        {
          "id": 3,
          "text": "MgSO4 regimen"
        },
        {
          "id": 4,
          "text": "Platelet transfusion"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical scenario is suggestive of <strong>eclampsia and HELLP</strong> syndrome. The definitive management is the&nbsp;<strong>termination of pregnancy</strong>.</p>\n<p>In cases of <strong>pre-eclampsia</strong>,<strong> indications for termination </strong>of pregnancy, irrespective of gestational age, are as follows:</p>\n<ul>\n<li>Eclampsia (give MgSO<sub>4 </sub>followed by induction of labor)</li>\n<li>HELLP syndrome</li>\n<li>Persistent symptoms of severe pre-eclampsia or severe hypertension</li>\n<li>Pulmonary edema</li>\n<li>Significant renal dysfunction, coagulopathy</li>\n<li>Abruption of placenta</li>\n<li>Fetal compromise</li>\n</ul>\n<p>In <strong>mild</strong> pre-eclampsia,&nbsp;<strong>steroids</strong> are given and the patient is delivered at <strong>37 weeks.</strong></p>\n<p>In <strong>severe</strong> pre-eclampsia:</p>\n<ul>\n<li>If pregnancy is&nbsp;<strong>&gt;34</strong> weeks -&nbsp;<strong>MgSO<sub>4 </sub></strong>is given for prophylaxis of eclampsia and the pregnancy is <strong>terminated</strong>.</li>\n<li>If pregnancy is at <strong>27-34</strong>&nbsp;weeks - in the <strong>absence of contraindications,&nbsp;expectant </strong>management is followed and the baby is delivered at <strong>34</strong> <strong>weeks</strong>, as shown below in the flowchart.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/578e59aad58d4a2ca0339e048d09aed7x1280x2024.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2059",
      "difficulty": "easy"
    },
    {
      "text": "A pre-eclamptic patient at 30 weeks of gestation is rushed to the hospital as she suddenly lost her vision 1 hour ago. During admission, she has a seizure. Which of the given statements is correct?",
      "choices": [
        {
          "id": 1,
          "text": "Convulsions within 7 days of delivery are called postpartum eclampsia"
        },
        {
          "id": 2,
          "text": "Thrombocytosis is likely to be found"
        },
        {
          "id": 3,
          "text": "Blindness due to this condition is usually reversible"
        },
        {
          "id": 4,
          "text": "The seizure is usually focal"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The clinical scenario is suggestive of eclampsia.&nbsp;<strong>Blindness</strong> due to eclampsia is usually&nbsp;<strong>reversible.</strong></p>\n<p>Blindness due to eclampsia can be due to a central or peripheral cause. It is irreversible only if the etiology is a combination of retinal infarction and bilateral lateral geniculate nuclei lesions.</p>\n<p>Option A: <strong>Convulsions</strong>&nbsp;<strong>within</strong>&nbsp;<strong>48 hours</strong>&nbsp;of delivery are called <strong>postpartum eclampsia</strong>.</p>\n<p>Option B: The&nbsp;most common hematological finding in pregnancy-induced hypertension is <strong>thrombocytopenia</strong>.</p>\n<p>Option D: The seizures are <strong>generalized seizures</strong>.</p>\n<p>Note:&nbsp;The most common cause of death in patients with eclampsia is intracerebral hemorrhage.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9710",
      "difficulty": "medium"
    },
    {
      "text": "A G3P2 patient with preeclampsia develops seizures and is started on the Pritchard regimen. What level of serum magnesium should be maintained in this patient in order to prevent seizures?",
      "choices": [
        {
          "id": 1,
          "text": "4-7 meq/L"
        },
        {
          "id": 2,
          "text": "7-10 meq/L"
        },
        {
          "id": 3,
          "text": "1-3 meq/L"
        },
        {
          "id": 4,
          "text": "6-8 meq/L"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical picture is suggestive of<strong> eclampsia</strong> and to control fits, optimum serum magnesium levels of<strong> 4-7 mEq/L </strong>have to be maintained.&nbsp;</p>\n<p>MgSO<sub>4</sub> regimens for management of eclampsia and severe pre-eclampsia:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Regimen</strong></p>\n</td>\n<td>\n<p><strong>Loading Dose</strong></p>\n</td>\n<td>\n<p><strong>Maintenance Dose</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Intramuscular&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;(Pritchard)</strong></p>\n</td>\n<td>\n<p>4 g (20% solution) IV over 3&ndash;5 min <br />followed by <br />10 g (50%), deep IM (5 g in each buttock)</p>\n</td>\n<td>\n<p>5 g (50%) IM 4 hourly in alternate buttocks</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Intravenous (Zuspan or&nbsp; &nbsp;Sibai)</strong></p>\n</td>\n<td>\n<p>4g IV slow over 15&ndash;20 minutes</p>\n</td>\n<td>\n<p>1&ndash;2 g/hr IV infusion</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2063",
      "difficulty": "easy"
    },
    {
      "text": "The mechanism of action of MgSo4 includes all, except:",
      "choices": [
        {
          "id": 1,
          "text": "It is a membrane stabiliser"
        },
        {
          "id": 2,
          "text": "It is a neuroprotector"
        },
        {
          "id": 3,
          "text": "It reduces motor endplate sensitivity to Ach"
        },
        {
          "id": 4,
          "text": "It blocks neuronal sodium influx"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>MgSO4&nbsp;<strong>blocks calcium influx, </strong>not sodium.</p>\n<p>Mechanism of action of MgSO<sub>4</sub>:</p>\n<ul>\n<li>It is a <strong>membrane stabilizer</strong> and acts as a <strong>neuroprotector</strong> by <strong>reducing motor endplate sensitivity to Ach.</strong></li>\n<li>It <strong>blocks neuronal calcium influx.</strong></li>\n<li>It reduces the presynaptic release of the neurotransmitter glutamate.</li>\n<li>It blocks&nbsp;glutaminergic NMDA receptors and&nbsp;potentiates&nbsp;adenosine action.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2064",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is an indication to skip the next dose in a patient with severe pre-eclampsia taking MgSO4 prophylactically?",
      "choices": [
        {
          "id": 1,
          "text": "Knee jerks are sluggish"
        },
        {
          "id": 2,
          "text": "Urine output exceeds 30 ml/hr"
        },
        {
          "id": 3,
          "text": "Respiratory rate more than 14 /min"
        },
        {
          "id": 4,
          "text": "Heart rate more than 100/min"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Repeat injections of MgSO<sub>4</sub></strong> are given only if <strong>knee jerks are present</strong>.</p>\n<p>The next dose of&nbsp;MgSO<sub>4&nbsp;</sub>is only given when all signs of magnesium toxicity are absent.</p>\n<p>Signs of magnesium toxicity:</p>\n<ul>\n<li>Loss of deep tendon reflexes</li>\n<li>Decreased respiratory rate (<strong>&lt;12</strong> per min)</li>\n<li>Urine output <strong>&lt;30</strong> ml/hr</li>\n<li>Chest pain, heart block</li>\n</ul>\n<p>Management of magnesium toxicity:</p>\n<ul>\n<li>Stop magnesium therapy</li>\n<li>Estimation of serum magnesium and creatinine levels</li>\n<li>Injection of calcium gluconate 10 ml (10% solution) IV</li>\n</ul>\n<p>Side effects of MgSO<sub>4</sub>:</p>\n<ul>\n<li>Anuria</li>\n<li>Pulmonary edema.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2066",
      "difficulty": "easy"
    },
    {
      "text": "A pregnant woman with pre-eclampsia is started on prophylactic MgSO4 in view of signs of impending eclampsia. An hour later, examination reveals RR - 16 breaths/minute and absent patellar reflexes. What is her plasma concentration of MgSO4 most likely to be?",
      "choices": [
        {
          "id": 1,
          "text": "6-8 mEq/L"
        },
        {
          "id": 2,
          "text": "14-16 mEq/L"
        },
        {
          "id": 3,
          "text": "16-30 mEq/L"
        },
        {
          "id": 4,
          "text": "10-12 mEq/L"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Patellar reflexes disappear</strong> when plasma magnesium concentration reaches 10 mEq/L. As there is no respiratory depression, the plasma concentration is likely to be <strong>10-12 mEq/L.</strong></p>\n<p>The disappearance of the<strong> patellar reflex</strong> is the<strong> first sign </strong>of impending magnesium <strong>toxicity. </strong>MgSO4 is prophylactically used in impending eclampsia, severe pre-eclampsia, and HELLP syndrome.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Signs of magnesium toxicity</strong></td>\n<td><strong>Plasma concentrations of magnesium (mEq/L)</strong></td>\n</tr>\n<tr>\n<td>Loss of patellar reflex</td>\n<td>10–12</td>\n</tr>\n<tr>\n<td>Respiratory depression</td>\n<td>12-13 </td>\n</tr>\n<tr>\n<td>Cardiac arrest</td>\n<td>&gt;30 </td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2068",
      "difficulty": "medium"
    },
    {
      "text": "Magnesium sulphate has no role in:",
      "choices": [
        {
          "id": 1,
          "text": "Prevention of seizures in severe pre-eclampsia"
        },
        {
          "id": 2,
          "text": "Prevention of recurrent seizures in eclampsia"
        },
        {
          "id": 3,
          "text": "Prevention of RDS in premature baby"
        },
        {
          "id": 4,
          "text": "Reducing contractility of uterus"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Magnesium sulfate has <strong>no role </strong>in the prevention of respiratory distress syndrome (RDS) in a premature baby, where there is a deficit of surfactant (which results in alveolar collapse).</p>\n<p><strong>Magnesium</strong> in the MgSO<sub>4</sub>&nbsp;competes with <strong>calcium</strong> on <strong>voltage-gated</strong> <strong>calcium</strong> channels, thereby altering its uptake and release. Functions of MgSO<sub>4</sub>&nbsp;include :</p>\n<ul>\n<li><strong>Membrane</strong> <strong>protector</strong> and neuro stabilizer. It is used in the <strong>prevention</strong> of <strong>cerebral</strong> <strong>palsy</strong> in very low birth weight neonates.</li>\n<li>Reduction of <strong>motor</strong> <strong>endplate </strong>sensitivity to <strong>acetylcholine</strong>, and thus is used as an adjunct in the <strong>management</strong> of <strong>acute</strong> <strong>severe</strong> <strong>asthma</strong> in children and adults</li>\n<li>Blocking of <strong>neuronal</strong> <strong>calcium</strong> <strong>influx</strong>, and is thus used in the <strong>conservative</strong> <strong>management</strong> of pre-term labor (<strong>tocolytic</strong>, option D)</li>\n<li>Inducing <strong>cerebral</strong> <strong>vasodilatation</strong>, <strong>dilating</strong> the <strong>uterine</strong> <strong>arteries</strong>, increasing the production of endothelial prostacyclin, and <strong>inhibiting</strong> <strong>platelet</strong> <strong>activation</strong>. Hence it is used in the management of <strong>pre-eclampsia </strong>(option A) and to prevent progression to <strong>eclampsia</strong> (option A).</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7495",
      "difficulty": "medium"
    },
    {
      "text": "A primigravida at 33 weeks of gestation was rushed to the hospital with recurrent seizures. Her husband says that prior to the seizures, she had complained of a headache and visual disturbances. She was on antihypertensives from the first trimester and there is no history of neurological disease. Which of the following is true regarding her management?",
      "choices": [
        {
          "id": 1,
          "text": "First step of management is intravenous MgSO4"
        },
        {
          "id": 2,
          "text": "Diazepam is recommended as an anticonvulsant if MgSO4 fails"
        },
        {
          "id": 3,
          "text": "Treatment may be based on recommendations from the Magpie trial"
        },
        {
          "id": 4,
          "text": "Maternal alkalosis commonly occurs and needs correction"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The clinical scenario is suggestive of <strong>eclampsia</strong> and management may be based on recommendations from the <strong>Magpie trial.</strong></p>\n<p>The Magpie trial showed that <strong>prophylactic</strong> use of <strong>magnesium sulfate </strong>lowers the risk of eclampsia.</p>\n<p>The <strong>first step</strong> in the&nbsp;management of eclampsia is maintaining the&nbsp;<strong>airway</strong>, ensuring oxygen delivery to both mother and fetus. Then,&nbsp;<strong>MgSO<sub>4&nbsp;</sub></strong>is administered to&nbsp;<strong>control seizures</strong>.</p>\n<p><strong>Thiopentone</strong> &gt; phenobarbitone may be used to <strong>control seizures</strong>. No attempt should be made to shorten the convulsion using <strong>diazepam</strong> as it often leads to <strong>thrombophlebitis</strong> and <strong>respiratory depression.&nbsp;</strong></p>\n<p><strong>Maternal acidosis</strong> usually occurs and is corrected when present.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2040",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is true regarding eclampsia?<div class='question-desc-html'><ol>\n<li>Antepartum onset has the worst prognosis</li>\n<li>The outcome depends on the severity of hypertension.</li>\n<li>The most common cause of death is renal failure.</li>\n<li>The most common MRI finding is subcortical white matter edema.</li>\n<li>It most commonly occurs during the intrapartum period</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 3"
        },
        {
          "id": 2,
          "text": "3, 5"
        },
        {
          "id": 3,
          "text": "2, 4"
        },
        {
          "id": 4,
          "text": "1, 4"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Antepartum eclampsia</strong> has the <strong>worst prognosis</strong> and the most common <strong>MRI</strong> finding of eclampsia is <strong>subcortical white matter edema</strong>.</p>\n<p>Antepartum eclampsia is&nbsp;the most common type of eclampsia. It&nbsp;has the highest rate of maternal mortality.</p>\n<p>The<strong> outcome</strong> of eclampsia depends on the <strong>duration of hypertension</strong> and not severity.&nbsp;The most<strong>&nbsp;common cause of death</strong> in eclampsia and severe pre-eclampsia is <strong>intracranial bleeding.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9712",
      "difficulty": "medium"
    },
    {
      "text": "A pregnant lady with PIH was being monitored with bed rest in supine position. Which of the following is a complication of the below representation?",
      "choices": [
        {
          "id": 1,
          "text": "Ascending aorta syndrome"
        },
        {
          "id": 2,
          "text": "Superior vena caval syndrome"
        },
        {
          "id": 3,
          "text": "Abdominal aorta syndrome"
        },
        {
          "id": 4,
          "text": "Supine venacava syndrome"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Supine vena cava syndrome</strong> is the complication of the given representation. The image shows compression of the <strong>inferior vena cava</strong> by the gravid uterus which can sometimes lead to<strong> supine hypotension.</strong></p>\n<p>During <strong>late pregnancy</strong>, the <strong>gravid uterus</strong> compresses the <strong>great vessels</strong> against the hard <strong>spine</strong>, when the<strong> patient</strong> is in the&nbsp;<strong>supine</strong> position. Of the two vessels, the <strong>vena cava</strong> is compressed, but the aorta, owing to its structure&nbsp;is relatively resistant.</p>\n<p>Normally, the <strong>vena cava compression</strong> results in opening up collateral circulation by means of paravertebral and azygous veins but in some cases, when the <strong>collateral circulation fails to open up</strong>, the <strong>venous return of the heart</strong> may be seriously <strong>curtailed&nbsp;</strong>resulting in <strong>hypotension,</strong> <strong>tachycardia</strong>,&nbsp;and <strong>syncope</strong> and is called supine vena cava&nbsp;syndrome.</p>\n<p>The normal blood pressure is quickly restored by turning the patient to the&nbsp;lateral position.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/8d89ac892aa7494bad6ee4d5ecd4cd0d.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0656",
      "difficulty": "medium"
    }
  ]
}